On Friday, KalVista Pharmaceuticals Inc (NASDAQ: KALV) was -4.27% drop from the session before settling in for the closing price of $16.15. A 52-week range for KALV has been $7.30 – $17.30.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -17.63%. When this article was written, the company’s average yearly earnings per share was at 87.71%. With a float of $37.84 million, this company’s outstanding shares have now reached $50.54 million.
KalVista Pharmaceuticals Inc (KALV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward KalVista Pharmaceuticals Inc stocks. The insider ownership of KalVista Pharmaceuticals Inc is 25.14%, while institutional ownership is 97.14%. The most recent insider transaction that took place on Dec 08 ’25, was worth 120,424. In this transaction CHIEF EXECUTIVE OFFICER of this company sold 7,294 shares at a rate of $16.51, taking the stock ownership to the 424,520 shares. Before that another transaction happened on Nov 24 ’25, when Company’s Chief Commercial Officer sold 3,813 for $13.45, making the entire transaction worth $51,289. This insider now owns 39,728 shares in total.
KalVista Pharmaceuticals Inc (KALV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 87.71% per share during the next fiscal year.
KalVista Pharmaceuticals Inc (NASDAQ: KALV) Trading Performance Indicators
You can see what KalVista Pharmaceuticals Inc (KALV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 546.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00 and is forecasted to reach 0.91 in one year’s time.
Technical Analysis of KalVista Pharmaceuticals Inc (KALV)
As of the previous 9 days, the stock’s Stochastic %D was 68.11%.
During the past 100 days, KalVista Pharmaceuticals Inc’s (KALV) raw stochastic average was set at 73.29%, which indicates a significant increase from 29.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.89 in the past 14 days, which was higher than the 0.80 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.82, while its 200-day Moving Average is $13.07. Now, the first resistance to watch is $16.17. This is followed by the second major resistance level at $16.87. The third major resistance level sits at $17.29. If the price goes on to break the first support level at $15.04, it is likely to go to the next support level at $14.62. The third support level lies at $13.92 if the price breaches the second support level.
KalVista Pharmaceuticals Inc (NASDAQ: KALV) Key Stats
There are 50,546K outstanding shares of the company, which has a market capitalization of 781.45 million. As of now, sales total 0 K while income totals -183,440 K. Its latest quarter income was 13,690 K while its last quarter net income were -49,480 K.
